Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors. For more information, visit www.seagen.com

 

Chat with the Seattle Genetics Team

Tom Liptak, R.Ph

Registered Pharmacist
Senior Oncology Account Manager, Sales-Northeast Region
T: 412-607-0250      C: 412-607-0250                      
tliptak@seagen.com

Mary Jo Capozzoli, RN, BSN

Senior Oncology Account Manager, Seagen

412-400-2742

mcapozzoli@seagen.com

Jim Turconi

Senior Oncology Account Manager, Seagen

jturconi@seagen.com

412-585-3532

 

 

                           

                            PADCEV HCP Homepage

                            PADCEV (enfortumab vedotin-ejfv) Prescribing Information

 

                            ADCETRIS HCP Website 
                            https://seagendocs.com/Adcetris_Full_Ltr_Master.pdf

                            ADCETRIS 5-Year ECHELON-1 Update

                            Request a Rep to Learn More About ADCETRIS

                            ADCETRIS Core Visual Aid

                            

                           TUKYSA (tucatinib) tablets Prescribing Information

                            TUKYSA HCP Website

                            Request a Rep to Learn More About TUKYSA

                            TUKYSA Dosing and Administration Guide

                            Medical Affairs Scientific Engagement Experience

                            Submit A Medical Information Request

 

Back to the Virtual Exhibit Hall